Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 62.50
0.00 (0.00%)
Jun 16, 2026, 8:00 AM GMT
Arecor Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 0.66 | -10.24 | -8.55 | -9.26 | -6.17 |
Depreciation & Amortization | 0.21 | 0.35 | 0.49 | 0.34 | 0.17 |
Other Amortization | 0.01 | 0.01 | 0.01 | 0 | - |
Loss (Gain) From Sale of Assets | -4.98 | - | - | - | - |
Stock-Based Compensation | 0.32 | 0.16 | 0.64 | 0.5 | 0.48 |
Other Operating Activities | 0.63 | 5.06 | -0.48 | -0.71 | 0.48 |
Change in Accounts Receivable | -0.37 | 0.38 | -1 | -0.05 | -1.26 |
Change in Inventory | - | - | 0.36 | 0.59 | - |
Change in Accounts Payable | 0.32 | -1.07 | 1.38 | -2.2 | 0.84 |
Change in Other Net Operating Assets | 0.11 | -0.35 | 1.33 | - | - |
Operating Cash Flow | -2.36 | -9.33 | -5.84 | -10.78 | -5.45 |
Capital Expenditures | -0.1 | -0.01 | -0.15 | -0.3 | -0.07 |
Sale of Property, Plant & Equipment | 0.01 | - | 0.01 | - | - |
Cash Acquisitions | - | - | - | 0.28 | - |
Sale (Purchase) of Intangibles | 5.19 | - | - | -0.05 | - |
Investment in Securities | -3.11 | 1.64 | 6.38 | -8.04 | - |
Other Investing Activities | 0.47 | 0.09 | 0.28 | 0.11 | 0 |
Investing Cash Flow | 2.46 | 1.72 | 6.52 | -7.99 | -0.07 |
Long-Term Debt Issued | - | 0.01 | 0.04 | - | 2.5 |
Short-Term Debt Repaid | - | - | - | -0.3 | - |
Long-Term Debt Repaid | -0.09 | -0.09 | -0.2 | -0.17 | -0.11 |
Total Debt Repaid | -0.09 | -0.09 | -0.2 | -0.46 | -0.11 |
Net Debt Issued (Repaid) | -0.09 | -0.08 | -0.17 | -0.46 | 2.39 |
Issuance of Common Stock | - | 6.42 | - | 6 | 20 |
Other Financing Activities | -0.06 | -0.69 | -0.02 | -0.38 | -1.46 |
Financing Cash Flow | -0.15 | 5.65 | -0.18 | 5.16 | 20.93 |
Foreign Exchange Rate Adjustments | -0.18 | 0.11 | -0.17 | 0.06 | 0.01 |
Net Cash Flow | -0.24 | -1.85 | 0.33 | -13.55 | 15.42 |
Free Cash Flow | -2.46 | -9.34 | -5.99 | -11.08 | -5.52 |
Free Cash Flow Margin | -143.64% | -568.35% | -131.03% | -461.05% | -476.60% |
Free Cash Flow Per Share | -0.06 | -0.28 | -0.20 | -0.38 | -0.24 |
Cash Interest Paid | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
Cash Income Tax Paid | -0.36 | - | - | -0.73 | -0.76 |
Levered Free Cash Flow | 4.88 | -5.2 | -3 | -7.06 | -3.6 |
Unlevered Free Cash Flow | 4.88 | -5.19 | -2.99 | -7.05 | -3.59 |
Change in Working Capital | 0.06 | -1.04 | 2.06 | -1.66 | -0.42 |